Parvizi Surgical Innovation Joins Forces with PrecisionOS
augmented reality

Parvizi Surgical Innovation Joins Forces with PrecisionOS

PrecisionOS™ continues to garner support through an investment and partnership with Parvizi Surgical Innovation, LLC (PSI). The clinically-validated software company brings virtual reality (VR) and augmented reality (AR) at par with medical-grade and industry-recognized standards to the world of surgical training and education.

PrecisionOS was established by Danny P. Goel, MD who is a seasoned orthopedic surgeon on a quest to create revolutionary educational mediums for surgical training. He brought together a remarkable team of industry experts spanning surgical education, gaming, and even film to create the innovation-centric company.

On the announcement of the partnership, he said, “This is a significant milestone for our company, which has provided world-class teaching experiences across 25 countries in over 300 cities within our medical device and institutional partner network.”

“Reimagining surgical education has been at the forefront of our highly advanced and innovative approach to improve patient outcomes. We are excited to introduce our partnership with PSI, which shares a similar patient-centric vision and values,” he added.

On the other side, PSI unites industry-leading surgical experts that have a passion for contemporary technology in a bid to drive the industry forward. Its team comprises of almost 100 clinicians spread across the foremost educational institutions globally. The company devotes its investments towards long-term quality care and lays extensive focus on healthcare providers and patients’ experiences.

Dr. Javad Parvizi, the Founder & CEO at PSI, said, “The PrecisionOS platform optimizes surgical education through cutting-edge gaming and simulation capabilities while providing endless growth opportunities for industry-wide surgical advancement.”

He continued, “The technology offers a proven model for success given its robust clinical validation from two recent, randomized controlled trials and the support of its experienced and diverse surgeon advisory board. We look forward to aligning ourselves with PrecisionOS as they continue to pave a strong path forward for supporting surgeons within our operating rooms, as well as researchers, industry leaders, and all other parties involved in providing elevated and modernized surgical experiences.”

Follow us on LinkedIn

Read other Articles